Medical Devices & Consumables

Global Cardiac Biomarkers Testing Market Insights, Forecast to 2030

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
Market Analysis and Insights: Global Cardiac Biomarkers Testing Market
The global Cardiac Biomarkers Testing market is projected to grow from US$ 7817 million in 2024 to US$ 11410 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
Report Covers:
This report presents an overview of global market for Cardiac Biomarkers Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cardiac Biomarkers Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cardiac Biomarkers Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cardiac Biomarkers Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cardiac Biomarkers Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cardiac Biomarkers Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
ROCHE
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
Segment by Type
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Segment by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cardiac Biomarkers Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Biomarkers Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiac Biomarkers Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Myocardial Muscle Creatine Kinase (CK-MB)
1.2.3 Troponins (T and I)
1.2.4 Myoglobin
1.2.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
1.2.6 Ischemia-modified Albumin (IMA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Biomarkers Testing Market Perspective (2019-2030)
2.2 Global Cardiac Biomarkers Testing Growth Trends by Region
2.2.1 Cardiac Biomarkers Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cardiac Biomarkers Testing Historic Market Size by Region (2019-2024)
2.2.3 Cardiac Biomarkers Testing Forecasted Market Size by Region (2025-2030)
2.3 Cardiac Biomarkers Testing Market Dynamics
2.3.1 Cardiac Biomarkers Testing Industry Trends
2.3.2 Cardiac Biomarkers Testing Market Drivers
2.3.3 Cardiac Biomarkers Testing Market Challenges
2.3.4 Cardiac Biomarkers Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cardiac Biomarkers Testing by Players
3.1.1 Global Cardiac Biomarkers Testing Revenue by Players (2019-2024)
3.1.2 Global Cardiac Biomarkers Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cardiac Biomarkers Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cardiac Biomarkers Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cardiac Biomarkers Testing Market Concentration Ratio
3.4.1 Global Cardiac Biomarkers Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Testing Revenue in 2023
3.5 Global Key Players of Cardiac Biomarkers Testing Head office and Area Served
3.6 Global Key Players of Cardiac Biomarkers Testing, Product and Application
3.7 Global Key Players of Cardiac Biomarkers Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Biomarkers Testing Breakdown Data by Type
4.1 Global Cardiac Biomarkers Testing Historic Market Size by Type (2019-2024)
4.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2025-2030)
5 Cardiac Biomarkers Testing Breakdown Data by Application
5.1 Global Cardiac Biomarkers Testing Historic Market Size by Application (2019-2024)
5.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cardiac Biomarkers Testing Market Size (2019-2030)
6.2 North America Cardiac Biomarkers Testing Market Size by Type
6.2.1 North America Cardiac Biomarkers Testing Market Size by Type (2019-2024)
6.2.2 North America Cardiac Biomarkers Testing Market Size by Type (2025-2030)
6.2.3 North America Cardiac Biomarkers Testing Market Share by Type (2019-2030)
6.3 North America Cardiac Biomarkers Testing Market Size by Application
6.3.1 North America Cardiac Biomarkers Testing Market Size by Application (2019-2024)
6.3.2 North America Cardiac Biomarkers Testing Market Size by Application (2025-2030)
6.3.3 North America Cardiac Biomarkers Testing Market Share by Application (2019-2030)
6.4 North America Cardiac Biomarkers Testing Market Size by Country
6.4.1 North America Cardiac Biomarkers Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cardiac Biomarkers Testing Market Size by Country (2019-2024)
6.4.3 North America Cardiac Biomarkers Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cardiac Biomarkers Testing Market Size (2019-2030)
7.2 Europe Cardiac Biomarkers Testing Market Size by Type
7.2.1 Europe Cardiac Biomarkers Testing Market Size by Type (2019-2024)
7.2.2 Europe Cardiac Biomarkers Testing Market Size by Type (2025-2030)
7.2.3 Europe Cardiac Biomarkers Testing Market Share by Type (2019-2030)
7.3 Europe Cardiac Biomarkers Testing Market Size by Application
7.3.1 Europe Cardiac Biomarkers Testing Market Size by Application (2019-2024)
7.3.2 Europe Cardiac Biomarkers Testing Market Size by Application (2025-2030)
7.3.3 Europe Cardiac Biomarkers Testing Market Share by Application (2019-2030)
7.4 Europe Cardiac Biomarkers Testing Market Size by Country
7.4.1 Europe Cardiac Biomarkers Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cardiac Biomarkers Testing Market Size by Country (2019-2024)
7.4.3 Europe Cardiac Biomarkers Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cardiac Biomarkers Testing Market Size (2019-2030)
8.2 China Cardiac Biomarkers Testing Market Size by Type
8.2.1 China Cardiac Biomarkers Testing Market Size by Type (2019-2024)
8.2.2 China Cardiac Biomarkers Testing Market Size by Type (2025-2030)
8.2.3 China Cardiac Biomarkers Testing Market Share by Type (2019-2030)
8.3 China Cardiac Biomarkers Testing Market Size by Application
8.3.1 China Cardiac Biomarkers Testing Market Size by Application (2019-2024)
8.3.2 China Cardiac Biomarkers Testing Market Size by Application (2025-2030)
8.3.3 China Cardiac Biomarkers Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cardiac Biomarkers Testing Market Size (2019-2030)
9.2 Asia Cardiac Biomarkers Testing Market Size by Type
9.2.1 Asia Cardiac Biomarkers Testing Market Size by Type (2019-2024)
9.2.2 Asia Cardiac Biomarkers Testing Market Size by Type (2025-2030)
9.2.3 Asia Cardiac Biomarkers Testing Market Share by Type (2019-2030)
9.3 Asia Cardiac Biomarkers Testing Market Size by Application
9.3.1 Asia Cardiac Biomarkers Testing Market Size by Application (2019-2024)
9.3.2 Asia Cardiac Biomarkers Testing Market Size by Application (2025-2030)
9.3.3 Asia Cardiac Biomarkers Testing Market Share by Application (2019-2030)
9.4 Asia Cardiac Biomarkers Testing Market Size by Region
9.4.1 Asia Cardiac Biomarkers Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cardiac Biomarkers Testing Market Size by Region (2019-2024)
9.4.3 Asia Cardiac Biomarkers Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Cardiac Biomarkers Testing Introduction
11.1.4 Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Introduction
11.2.4 Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.2.5 Becton, Dickinson and Company Recent Developments
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Cardiac Biomarkers Testing Introduction
11.3.4 BioMerieux Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.3.5 BioMerieux Recent Developments
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Details
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.4.5 Bio-Rad Laboratories, Inc. Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Cardiac Biomarkers Testing Introduction
11.5.4 Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.5.5 Danaher Corporation Recent Developments
11.6 ROCHE
11.6.1 ROCHE Company Details
11.6.2 ROCHE Business Overview
11.6.3 ROCHE Cardiac Biomarkers Testing Introduction
11.6.4 ROCHE Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.6.5 ROCHE Recent Developments
11.7 Siemens AG
11.7.1 Siemens AG Company Details
11.7.2 Siemens AG Business Overview
11.7.3 Siemens AG Cardiac Biomarkers Testing Introduction
11.7.4 Siemens AG Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.7.5 Siemens AG Recent Developments
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Details
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.8.5 Thermo Fisher Scientific, Inc. Recent Developments
11.9 PerkinElmer Inc.
11.9.1 PerkinElmer Inc. Company Details
11.9.2 PerkinElmer Inc. Business Overview
11.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Introduction
11.9.4 PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.9.5 PerkinElmer Inc. Recent Developments
11.10 Tosoh Corporation
11.10.1 Tosoh Corporation Company Details
11.10.2 Tosoh Corporation Business Overview
11.10.3 Tosoh Corporation Cardiac Biomarkers Testing Introduction
11.10.4 Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.10.5 Tosoh Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Myocardial Muscle Creatine Kinase (CK-MB)
Table 3. Key Players of Troponins (T and I)
Table 4. Key Players of Myoglobin
Table 5. Key Players of Brain Natriuretic Peptide (BNPs) or NT-proBNP
Table 6. Key Players of Ischemia-modified Albumin (IMA)
Table 7. Key Players of Others
Table 8. Global Cardiac Biomarkers Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 9. Global Cardiac Biomarkers Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Cardiac Biomarkers Testing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Cardiac Biomarkers Testing Market Share by Region (2019-2024)
Table 12. Global Cardiac Biomarkers Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Cardiac Biomarkers Testing Market Share by Region (2025-2030)
Table 14. Cardiac Biomarkers Testing Market Trends
Table 15. Cardiac Biomarkers Testing Market Drivers
Table 16. Cardiac Biomarkers Testing Market Challenges
Table 17. Cardiac Biomarkers Testing Market Restraints
Table 18. Global Cardiac Biomarkers Testing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Cardiac Biomarkers Testing Revenue Share by Players (2019-2024)
Table 20. Global Top Cardiac Biomarkers Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Biomarkers Testing as of 2023)
Table 21. Global Cardiac Biomarkers Testing Industry Ranking 2022 VS 2023 VS 2024
Table 22. Global 5 Largest Players Market Share by Cardiac Biomarkers Testing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of Cardiac Biomarkers Testing, Headquarters and Area Served
Table 24. Global Key Players of Cardiac Biomarkers Testing, Product and Application
Table 25. Global Key Players of Cardiac Biomarkers Testing, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cardiac Biomarkers Testing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2019-2024)
Table 29. Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2025-2030)
Table 31. Global Cardiac Biomarkers Testing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Cardiac Biomarkers Testing Revenue Share by Application (2019-2024)
Table 33. Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Cardiac Biomarkers Testing Revenue Share by Application (2025-2030)
Table 35. North America Cardiac Biomarkers Testing Market Size by Type (2019-2024) & (US$ Million)
Table 36. North America Cardiac Biomarkers Testing Market Size by Type (2025-2030) & (US$ Million)
Table 37. North America Cardiac Biomarkers Testing Market Size by Application (2019-2024) & (US$ Million)
Table 38. North America Cardiac Biomarkers Testing Market Size by Application (2025-2030) & (US$ Million)
Table 39. North America Cardiac Biomarkers Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. North America Cardiac Biomarkers Testing Market Size by Country (2019-2024) & (US$ Million)
Table 41. North America Cardiac Biomarkers Testing Market Size by Country (2025-2030) & (US$ Million)
Table 42. Europe Cardiac Biomarkers Testing Market Size by Type (2019-2024) & (US$ Million)
Table 43. Europe Cardiac Biomarkers Testing Market Size by Type (2025-2030) & (US$ Million)
Table 44. Europe Cardiac Biomarkers Testing Market Size by Application (2019-2024) & (US$ Million)
Table 45. Europe Cardiac Biomarkers Testing Market Size by Application (2025-2030) & (US$ Million)
Table 46. Europe Cardiac Biomarkers Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Europe Cardiac Biomarkers Testing Market Size by Country (2019-2024) & (US$ Million)
Table 48. Europe Cardiac Biomarkers Testing Market Size by Country (2025-2030) & (US$ Million)
Table 49. China Cardiac Biomarkers Testing Market Size by Type (2019-2024) & (US$ Million)
Table 50. China Cardiac Biomarkers Testing Market Size by Type (2025-2030) & (US$ Million)
Table 51. China Cardiac Biomarkers Testing Market Size by Application (2019-2024) & (US$ Million)
Table 52. China Cardiac Biomarkers Testing Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Cardiac Biomarkers Testing Market Size by Type (2019-2024) & (US$ Million)
Table 54. Asia Cardiac Biomarkers Testing Market Size by Type (2025-2030) & (US$ Million)
Table 55. Asia Cardiac Biomarkers Testing Market Size by Application (2019-2024) & (US$ Million)
Table 56. Asia Cardiac Biomarkers Testing Market Size by Application (2025-2030) & (US$ Million)
Table 57. Asia Cardiac Biomarkers Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 58. Asia Cardiac Biomarkers Testing Market Size by Region (2019-2024) & (US$ Million)
Table 59. Asia Cardiac Biomarkers Testing Market Size by Region (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Type (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Type (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Application (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Application (2025-2030) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 65. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Country (2019-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size by Country (2025-2030) & (US$ Million)
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Cardiac Biomarkers Testing Product
Table 70. Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 71. Abbott Laboratories Recent Developments
Table 72. Becton, Dickinson and Company Company Details
Table 73. Becton, Dickinson and Company Business Overview
Table 74. Becton, Dickinson and Company Cardiac Biomarkers Testing Product
Table 75. Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 76. Becton, Dickinson and Company Recent Developments
Table 77. BioMerieux Company Details
Table 78. BioMerieux Business Overview
Table 79. BioMerieux Cardiac Biomarkers Testing Product
Table 80. BioMerieux Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 81. BioMerieux Recent Developments
Table 82. Bio-Rad Laboratories, Inc. Company Details
Table 83. Bio-Rad Laboratories, Inc. Business Overview
Table 84. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Product
Table 85. Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 86. Bio-Rad Laboratories, Inc. Recent Developments
Table 87. Danaher Corporation Company Details
Table 88. Danaher Corporation Business Overview
Table 89. Danaher Corporation Cardiac Biomarkers Testing Product
Table 90. Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 91. Danaher Corporation Recent Developments
Table 92. ROCHE Company Details
Table 93. ROCHE Business Overview
Table 94. ROCHE Cardiac Biomarkers Testing Product
Table 95. ROCHE Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 96. ROCHE Recent Developments
Table 97. Siemens AG Company Details
Table 98. Siemens AG Business Overview
Table 99. Siemens AG Cardiac Biomarkers Testing Product
Table 100. Siemens AG Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 101. Siemens AG Recent Developments
Table 102. Thermo Fisher Scientific, Inc. Company Details
Table 103. Thermo Fisher Scientific, Inc. Business Overview
Table 104. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Product
Table 105. Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 106. Thermo Fisher Scientific, Inc. Recent Developments
Table 107. PerkinElmer Inc. Company Details
Table 108. PerkinElmer Inc. Business Overview
Table 109. PerkinElmer Inc. Cardiac Biomarkers Testing Product
Table 110. PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 111. PerkinElmer Inc. Recent Developments
Table 112. Tosoh Corporation Company Details
Table 113. Tosoh Corporation Business Overview
Table 114. Tosoh Corporation Cardiac Biomarkers Testing Product
Table 115. Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024) & (US$ Million)
Table 116. Tosoh Corporation Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiac Biomarkers Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Cardiac Biomarkers Testing Market Share by Type: 2023 VS 2030
Figure 3. Myocardial Muscle Creatine Kinase (CK-MB) Features
Figure 4. Troponins (T and I) Features
Figure 5. Myoglobin Features
Figure 6. Brain Natriuretic Peptide (BNPs) or NT-proBNP Features
Figure 7. Ischemia-modified Albumin (IMA) Features
Figure 8. Others Features
Figure 9. Global Cardiac Biomarkers Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global Cardiac Biomarkers Testing Market Share by Application: 2023 VS 2030
Figure 11. Myocardial Infarction Case Studies
Figure 12. Congestive Heart Failure Case Studies
Figure 13. Acute Coronary Syndrome Case Studies
Figure 14. Atherosclerosis Case Studies
Figure 15. Others Case Studies
Figure 16. Cardiac Biomarkers Testing Report Years Considered
Figure 17. Global Cardiac Biomarkers Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Cardiac Biomarkers Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Cardiac Biomarkers Testing Market Share by Region: 2023 VS 2030
Figure 20. Global Cardiac Biomarkers Testing Market Share by Players in 2023
Figure 21. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Biomarkers Testing as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Cardiac Biomarkers Testing Revenue in 2023
Figure 23. North America Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Cardiac Biomarkers Testing Market Share by Type (2019-2030)
Figure 25. North America Cardiac Biomarkers Testing Market Share by Application (2019-2030)
Figure 26. North America Cardiac Biomarkers Testing Market Share by Country (2019-2030)
Figure 27. United States Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Cardiac Biomarkers Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 30. Europe Cardiac Biomarkers Testing Market Share by Type (2019-2030)
Figure 31. Europe Cardiac Biomarkers Testing Market Share by Application (2019-2030)
Figure 32. Europe Cardiac Biomarkers Testing Market Share by Country (2019-2030)
Figure 33. Germany Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. China Cardiac Biomarkers Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 40. China Cardiac Biomarkers Testing Market Share by Type (2019-2030)
Figure 41. China Cardiac Biomarkers Testing Market Share by Application (2019-2030)
Figure 42. Asia Cardiac Biomarkers Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 43. Asia Cardiac Biomarkers Testing Market Share by Type (2019-2030)
Figure 44. Asia Cardiac Biomarkers Testing Market Share by Application (2019-2030)
Figure 45. Asia Cardiac Biomarkers Testing Market Share by Region (2019-2030)
Figure 46. Japan Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. South Korea Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Taiwan Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. India Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Australia Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Size YoY (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Share by Type (2019-2030)
Figure 54. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Share by Application (2019-2030)
Figure 55. Middle East, Africa, and Latin America Cardiac Biomarkers Testing Market Share by Country (2019-2030)
Figure 56. Brazil Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Mexico Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Turkey Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Israel Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GCC Countries Cardiac Biomarkers Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. Abbott Laboratories Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 63. Becton, Dickinson and Company Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 64. BioMerieux Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 65. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 66. Danaher Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 67. ROCHE Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 68. Siemens AG Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 69. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 70. PerkinElmer Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 71. Tosoh Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies